Literature DB >> 8356394

Detection of tumour necrosis factor alpha and interleukin-1 beta in the rheumatoid osteoarthritic cartilage-pannus junction by immunohistochemical methods.

V E Miller1, K Rogers, K D Muirden.   

Abstract

During inflammation the rheumatoid synovial membrane is invaded by a number of different cell types. When activated most of these cells produce cytokines including tumor necrosis factor alpha (TNF alpha) and interleukin-1 beta (IL-1 beta). These cytokines are believed to stimulate production of degradative enzymes and disturb the equilibrium between such enzymes and their inhibitors resulting in tissue damage. In this study we investigated the localisation of TNF alpha and IL-1 beta at the cartilage-pannus junction (CPJ). Here, cytokines are well placed to influence the integrity of articular cartilage. Tissue was derived from advanced rheumatoid (RA) and, as a comparison, osteoarthritic (OA) joints at the time of replacement surgery (arthroplasty). Antibody staining of fixed serial sections of tissue localised cells that were associated with IL-1 beta and TNF alpha. Cell markers for macrophages and endothelial cells were included to provide positive identification of the cytokine-associated cells. Analysis of these sections revealed that both TNF alpha and IL-1 beta were associated with macrophages, particularly those in the synovium overlying cartilage (pannus) and endothelial cells. Positive staining was seen at the CPJ in RA and in similarly located tissue in OA. The similar distribution of cytokines in OA was unexpected even if the overall numbers of tissue and infiltrating cells in the CPJ were different in the two diseases. This highlights the possible role played by endogenous inhibitors [1, 2] in influencing the degree of cytokine activity necessary to explain the different pathogenic mechanisms in RA and OA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8356394     DOI: 10.1007/bf00307738

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Interleukin 1 and tumor necrosis factor signal transduction mechanisms: potential targets for pharmacological control of inflammation.

Authors:  J Saklatvala; F Guesdon
Journal:  J Rheumatol Suppl       Date:  1992-01

Review 2.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

Review 3.  Recent insights into the pathogenesis of the proliferative lesion in rheumatoid arthritis.

Authors:  E D Harris
Journal:  Arthritis Rheum       Date:  1976 Jan-Feb

4.  The synovial membrane in osteoarthritis: a histological study including the characterisation of the cellular infiltrate present in inflammatory osteoarthritis using monoclonal antibodies.

Authors:  P A Revell; V Mayston; P Lalor; P Mapp
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

5.  The synovium-cartilage junction of the normal human knee. Implications for joint destruction and repair.

Authors:  S A Allard; M T Bayliss; R N Maini
Journal:  Arthritis Rheum       Date:  1990-08

Review 6.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

Review 7.  Chronic inflammatory joint diseases: natural inhibitors of interleukin 1 and tumor necrosis factor alpha.

Authors:  J M Dayer
Journal:  J Rheumatol Suppl       Date:  1991-02

8.  Synthesis of interleukin-1-like activity by normal rat chondrocytes in culture.

Authors:  N C Rath; A L Oronsky; S S Kerwar
Journal:  Clin Immunol Immunopathol       Date:  1988-04

Review 9.  Are cytokines involved in osteoarthritic pathophysiology?

Authors:  J P Pelletier; P J Roughley; J A DiBattista; R McCollum; J Martel-Pelletier
Journal:  Semin Arthritis Rheum       Date:  1991-06       Impact factor: 5.532

10.  Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs.

Authors:  B Haraoui; J P Pelletier; J M Cloutier; M P Faure; J Martel-Pelletier
Journal:  Arthritis Rheum       Date:  1991-02
View more
  2 in total

1.  Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor alpha in the knee-joints of patients with rheumatoid arthritis.

Authors:  J Neidel; M Schulze; J Lindschau
Journal:  Inflamm Res       Date:  1995-05       Impact factor: 4.575

Review 2.  Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky.

Authors:  Jim Middleton; Laure Americh; Regis Gayon; Denis Julien; Luc Aguilar; Francois Amalric; Jean-Philippe Girard
Journal:  Arthritis Res Ther       Date:  2004-03-08       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.